Published in Transplantation on January 15, 2010
Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection. J Virol (2013) 0.92
Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection. Am J Transplant (2013) 0.82
Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection. Cell Immunol (2014) 0.78
Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection. Am J Transplant (2016) 0.77
Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms. Curr Opin Organ Transplant (2016) 0.76
Murine heterotopic heart transplant technique. J Vis Exp (2014) 0.76
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10. J Neuroimmune Pharmacol (2015) 0.76
Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells. Am J Transplant (2010) 0.75
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (1992) 12.92
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol (1980) 10.30
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01
Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature (1998) 4.97
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med (2001) 3.16
Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol (1996) 2.96
Caspase activation is required for T cell proliferation. J Exp Med (1999) 2.74
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol (2000) 2.57
Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature (1987) 2.45
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med (1999) 2.12
Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci U S A (1994) 2.09
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1994) 2.04
Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol (2005) 1.93
Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant (2003) 1.76
Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med (1998) 1.57
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J Exp Med (2006) 1.57
Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A (1997) 1.48
Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant (2004) 1.33
CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest (2000) 1.30
Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation (1990) 1.03
The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc Natl Acad Sci U S A (2000) 1.03
Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol (1995) 1.02
Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation (1997) 0.99
Contribution of Fas ligand to cardiac allograft rejection. Int Immunol (1996) 0.97
Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transplant (2003) 0.96
Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation (1988) 0.96
A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol (2004) 0.93
CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation (1993) 0.92
Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation (1995) 0.91
Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles. Am J Transplant (2007) 0.90
Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy. Transplantation (2002) 0.87
Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT international registry for thoracic organ transplantation. Clin Transpl (2001) 0.85
CD4-positive suppressor cells block allotransplant rejection. J Immunol (1995) 0.85
CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion. J Immunol (2001) 0.82
Long-term results of cardiac transplantation. Annu Rev Med (1991) 0.78
CD4 T cells acutely reject cardiac allografts via direct donor recognition. Transplant Proc (1999) 0.77
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest (2006) 2.40
Lung transplant airway hypoxia: a diathesis to fibrosis? Am J Respir Crit Care Med (2010) 1.77
Mechanical ventilation after lung transplantation. An international survey of practices and preferences. Ann Am Thorac Soc (2014) 1.61
Proteomics as a tool for discovery: proteins implicated in Alzheimer's disease are highly expressed in normal pancreatic islets. J Proteome Res (2003) 1.60
Emphysema lung tissue gene expression profiling. Am J Respir Cell Mol Biol (2004) 1.49
NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med (2005) 1.45
Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med (2015) 1.45
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology (2006) 1.44
Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest (2007) 1.44
Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis. J Clin Invest (2007) 1.38
The role of nitric oxide and the unfolded protein response in cytokine-induced beta-cell death. Diabetes (2007) 1.28
Comprehensive assessment of chemokine expression profiles by flow cytometry. J Clin Invest (2010) 1.21
The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J Clin Virol (2002) 1.19
Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol (2005) 1.18
CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J Immunol (2002) 1.15
Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation (2005) 1.12
Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes (2011) 1.10
Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol (2006) 1.09
Redox modulation protects islets from transplant-related injury. Diabetes (2010) 0.98
Lobar torsion complicating bilateral lung transplantation. J Heart Lung Transplant (2003) 0.98
Bronchial blood supply after lung transplantation without bronchial artery revascularization. Curr Opin Organ Transplant (2010) 0.97
Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice. PLoS One (2013) 0.97
Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets. Diabetes (2007) 0.96
Medical complications of lung transplantation. Proc Am Thorac Soc (2009) 0.94
A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol (2004) 0.93
Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes (2005) 0.93
Progressive biliary destruction is independent of a functional tumor necrosis factor-alpha pathway in a rhesus rotavirus-induced murine model of biliary atresia. Viral Immunol (2007) 0.91
Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage. Endocrinology (2003) 0.91
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc (2011) 0.91
Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J Immunol (2012) 0.91
High efficiency of antiviral CD4(+) killer T cells. PLoS One (2013) 0.91
Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant (2005) 0.90
MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J Immunol (2005) 0.89
Frontiers in nephrology: the varied faces of natural killer cells in transplantation--contributions to both allograft immunity and tolerance. J Am Soc Nephrol (2007) 0.88
Non-invasive detection of acute allograft rejection in children by tissue Doppler imaging: myocardial velocities and myocardial acceleration during isovolumic contraction. J Heart Lung Transplant (2005) 0.86
Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.85
Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts. Cell Transplant (2008) 0.84
PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation. Am J Physiol Endocrinol Metab (2006) 0.84
Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity. J Virol (2011) 0.84
Four decades of vascularized heterotopic cardiac transplantation in the mouse. J Invest Surg (2013) 0.83
The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes (2003) 0.81
Outcome of acute graft rejection associated with hemodynamic compromise in pediatric heart transplant recipients. Pediatr Cardiol (2010) 0.80
Interferon-gamma is not a universal requirement for islet allograft survival. Transplantation (2002) 0.80
Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells. Transplantation (2007) 0.80
Predicting recovery: successful explant of a ventricular assist device in a child with dilated cardiomyopathy. J Heart Lung Transplant (2009) 0.79
Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. J Heart Lung Transplant (2005) 0.79
Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. J Heart Lung Transplant (2007) 0.79
BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant (2005) 0.79
Blood cultures for febrile patients in the acute care setting: too quick on the draw? J Am Acad Nurse Pract (2008) 0.79
Inhibition of autophagy increases apoptosis during re-warming after cold storage in renal tubular epithelial cells. Transpl Int (2014) 0.78
Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (2008) 0.78
Pancreatic islet xenotransplantation: barriers and prospects. Curr Diab Rep (2003) 0.78
Control of in vivo collateral damage generated by T cell immunity. J Immunol (2013) 0.78
The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients. Clin Transplant (2014) 0.77
Aging promotes acquisition of naive-like CD8+ memory T cell traits and enhanced functionalities. J Clin Invest (2016) 0.77
Evaluation of valganciclovir pharmacokinetics in lung transplant recipients. J Heart Lung Transplant (2012) 0.77
Recipient risk factors and lung transplant outcomes. Curr Opin Organ Transplant (2013) 0.77
CD4 T cells mediate cardiac xenograft rejection via host MHC Class II. J Heart Lung Transplant (2012) 0.77
Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients. Clin Transpl (2012) 0.77
Successful orthotopic heart transplant in an infant with an inflammatory myofibroblastic tumor of the left ventricle. J Heart Lung Transplant (2008) 0.77
Graft survival is better without prior surgery in cardiac transplantation for functionally univentricular hearts. J Heart Lung Transplant (2012) 0.76
Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms. Curr Opin Organ Transplant (2016) 0.76
The immunobiology of pancreatic islet transplantation. Adv Exp Med Biol (2004) 0.76
To help and help not. Nat Immunol (2004) 0.75
Long-term outcome of palliation with internal pulmonary artery bands after primary heart transplantation for hypoplastic left heart syndrome. Pediatr Cardiol (2009) 0.75
Respiratory viral infections. Preface. Semin Respir Crit Care Med (2011) 0.75
Steroid avoidance in pediatric heart transplantation results in excellent graft survival. Transplantation (2014) 0.75
IMMUNOBIOLOGY OF CELLULAR TRANSPLANTATION. Cell Transplant (1995) 0.75